NAIROBI, Kenya—Kenyan consultant pathologist Dr Ahmed Kalebi has been inducted into the inaugural Hall of Fame of The Pathologist, becoming the only African and the only representative from a low- or middle-income country among 15 professionals recognised for their lasting contributions to pathology and laboratory medicine.
The recognition, announced in October 2026, places Kalebi alongside distinguished figures whose work has helped shape the global pathology profession, including the late Professor Christopher D.M. Fletcher, formerly of Harvard Medical School and Brigham and Women’s Hospital, and the late Professor Richard Scolyer AO of the University of Sydney and Melanoma Institute Australia.
Kalebi’s induction follows six appearances on The Pathologist Power List in 2019, 2020, 2021, 2024, 2025 and 2026. His latest appearance recognised his efforts to advance diagnostic technology in Kenya and promote its responsible adoption in resource-constrained healthcare settings.
Reacting to the honour, Kalebi, the founder, executive chairman, chief executive officer and principal pathologist of Dr Kalebi Labs (DKL), described the induction as a significant professional milestone.
“I am deeply honoured and humbled to be inducted into the inaugural Hall of Fame alongside such illustrious and accomplished colleagues, including giants of our profession such as the late Professors Christopher Fletcher and Richard Scolyer,” he said.
He added that being the only African and the only inductee from a low- or middle-income country made the recognition particularly meaningful, describing it as an acknowledgement of the talent, resilience and potential of pathology and laboratory medicine professionals across Africa.
The recognition comes days after DKL, the specialised referral diagnostic laboratory he founded in Nairobi, marked its second anniversary on October 16, 2026.
Established in October 2024, the laboratory operates a paperless, digital-first model incorporating total laboratory automation, digital pathology, molecular diagnostics, flow cytometry, next-generation sequencing and artificial intelligence-enabled systems.
Kalebi established the facility to demonstrate how advanced diagnostic technologies can be developed and deployed in Africa to improve diagnostic quality, efficiency and patient care.
The laboratory combines specialist expertise with digital workflows and automated systems to support diagnostic services, reflecting Kalebi’s efforts to strengthen access to advanced laboratory medicine within Kenya.
He credited the colleagues who have supported his professional journey, particularly the DKL team, saying the recognition reflected their collective efforts.
“Whatever I have achieved over the years has been made possible by the dedication and support of many talented colleagues with whom I have had the privilege of working,” he said.
“Today, our remarkable team at DKL continues to demonstrate that world-class, cutting-edge laboratory medicine can be developed and delivered right here in Kenya. This recognition belongs to them as much as it does to me.”
With more than two decades of experience in diagnostic pathology, medical education, professional leadership and laboratory innovation, Kalebi has also advocated greater recognition of pathology’s role in healthcare.
Pathology involves examining tissues, cells and other specimens to help diagnose diseases and provide information clinicians use to guide treatment and patient management.
According to The Pathologist, its Hall of Fame provides permanent recognition to professionals who have appeared on its annual Power List at least five times, while also honouring influential figures who have died. The initiative is intended to recognise enduring contributions to the profession while opening opportunities on the annual Power List for emerging leaders and new perspectives.
Kalebi said his induction should also draw attention to African scientific expertise and the need to strengthen diagnostic services, institutions and professional capacity across the continent.
“Africa has exceptional talent in pathology, science and laboratory medicine. We must create more opportunities for that expertise to be recognised and celebrated internationally, while continuing to build the diagnostic capabilities, institutions and professional capacity that our healthcare systems urgently need at home,” he said.
